Dosimetric Uncertainties in Dominant Intraprostatic Lesion Simultaneous Boost Using Intensity Modulated Proton Therapy

Purpose: While intensity modulated proton therapy can deliver simultaneous integrated boost (SIB) to the dominant intraprostatic lesion (DIL) with high precision, it is sensitive to anatomic changes. We investigated the dosimetric effects from these changes based on pretreatment cone-beam computed t...

Full description

Bibliographic Details
Main Authors: Jun Zhou, PhD, Xiaofeng Yang, PhD, Chih-Wei Chang, PhD, Sibo Tian, MD, Tonghe Wang, PhD, Liyong Lin, PhD, Yinan Wang, MS, James Robert Janopaul-Naylor, MD, Pretesh Patel, MD, John D. Demoor, MS, Duncan Bohannon, MS, Alex Stanforth, MS, Bree Eaton, MD, Mark W. McDonald, MD, Tian Liu, PhD, Sagar Anil Patel, MD
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109421001846